Advancing to first-in-human clinical trials requires formulation development to design a successful sterile formulation that ...

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

For the first time, chemists have managed to create a type of molecule that was previously thought to be too unstable to ...

In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s ...

This article discusses continuous manufacturing and the increasing interest of this over traditional batch processing for ...

Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for ...

Data breaches occur in every industry, no matter the size. In particular, the pharmaceutical industry faces daily threats to ...

Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with ...

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could ...

Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

On Monday, Ascendis Pharma A/S (NASDAQ:ASND) granted Novo Nordisk A/S (NYSE:NVO) an exclusive worldwide license. The pact ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its propri ...